Neurochemical studies on the antifeines: a group of nootropic drugs.
Borodkin JuS
Razumovskaya
N I
NI
Belavtzveva
L M
LM
Kulikova
O G
OG
Lishnevskaya
E B
EB
Borisova GJu
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects*; D002110:Caffeine / Q000037:antagonists & inhibitors*; D002868:Chromosomal Proteins, Non-Histone / Q000378:metabolism; D000242:Cyclic AMP / Q000096:biosynthesis*; D005042:Etimizol / Q000031:analogs & derivatives / Q000494:pharmacology*; D007093:Imidazoles / Q000494:pharmacology*; D008297:Male; D010766:Phosphorylation; D011494:Protein Kinases / Q000378:metabolism; D011499:Protein Processing, Post-Translational / Q000187:drug effects; D012313:RNA / Q000096:biosynthesis*; D051381:Rats
D002868:Chromosomal Proteins, Non-Histone; D007093:Imidazoles; C042759:1-allylnorantifeine; D002110:Caffeine; D012313:RNA; D000242:Cyclic AMP; D011494:Protein Kinases; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D000262:Adenylyl Cyclases; D005042:Etimizol